Neutral on Divi’s Laboratories, target price Rs 2,245: Motilal Oswal

The brokerage has reduced its earnings estimate by 8 per cent/3 per cent for FY20/FY21 to factor in the delay in completion of capex activities.

Want to know more on

Neutral on Divi’s Laboratories, target price Rs 2,245: Motilal Oswal

click here go to market news source. Market news summary from The Economic Times.Author: …

From -

click here go to market news source.
Market news summary from The Economic Times.
Author:



Close

Market News Language


Market News Categories

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close